OneChain Immunotherapeutics is a spin-off Company from the Josep Carreras Leukemia Research Institute and ICREA, that aims to develop CAR-T candidates against different antigens as a treatment for hematological malignancies based on the know-how of Dr. Pablo Menéndez.
Company Details
- Employees
- 19
- Founded
- -
- Address
- Jobs
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.onechaintx.com
Onechain Immunotherapeutics Questions
Onechain Immunotherapeutics's website is http://www.onechaintx.com
Onechain Immunotherapeutics's LinkedIn profile is https://www.linkedin.com/company/onechain-immunotherapeutics
Onechain Immunotherapeutics has
19 employees.
View email and phone details for 19
employees at Onechain Immunotherapeutics.
Onechain Immunotherapeutics's industry is
Biotechnology Research
Onechain Immunotherapeutics's top competitors are
Aelix Therapeutics,
Mimark Diagnostics,
Aptadel Therapeutics,
Minoryx Therapeutics,
Oniria Therapeutics,
Splicebio,
Ona Therapeutics,
Deepull,
Nuage Therapeutics,
Oryzon Genomics Sa.
Onechain Immunotherapeutics's categories are Biotechnology Research
Onechain Immunotherapeutics's founding year is 2020
